Content
Breadcrumbs
Digitally uplifting quality to advance product supply and create competitive advantage
Part of the BTEC 2020–21 Seminar Series
Friday, Feb. 5, 2021
10:40–11:30 a.m.
Speaker: Anthony Mire-Sluis, Ph.D..
Head of Global Quality, AstraZeneca
Join us Friday, Feb. 5, 2021, for this presentation, whch will feature a short talk followed by a panel discussion. This seminar is co-hosted by KBI Biopharma.
About the presenter
Dr Mire-Sluis is currently head of Global Quality at AstraZeneca. He was previously vice president, North America, Contract, Singapore and Product Quality at Amgen Inc. Prior to working at Amgen, he was principal advisor, Regulatory Science and Review, Office of Biotechnology Products, CDER, and head of Analytical Sciences and Standards, Office of the Director, CBER, FDA, in Bethesda, Md.
He trained in genetics and biometry and has a PhD in cell biology and biochemistry. Dr Mire-Sluis was the head of the Cytokine Group in the Division of Immunobiology at the National Institute for Biological Standards and Control, Potters Bar, UK, where he specialized in the development of assays for the characterization and quantitation of biological products. He then became director of BioAnalytical Sciences at Genentech and prior to joining the FDA, was executive director of Analytical Sciences at CancerVax Corporation, San Diego.
He is the chairman of the IABS Biotherapeutics Committee, vice chairman of the USP Biologicals Characterization Expert Committee, and an expert for the International Committee for Harmonization.